About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials in Texas | 750 Studies

Clinical Trials Ovarian CancerTexas

Ovarian Cancer Clinical Trials in Texas

Find 750 clinical trials for ovarian cancer near Texas. Connect with research centers in your area.

All Ovarian Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 661-680 of 750 trials

CompletedCT Antigen TCR-redirected T Cells for Ovarian Cancer.This study, will take a subject's "T cells" and "teach" them to be able to recognize and attack the ovarian cancer cells.NCT01567891·Duarte, California and 4 others WithdrawnEfficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients.This study will assess the effect of IT-101 on delaying cancer progression in patients with platinum sensitive ovarian cancer.NCT00753740·Decatur, Illinois and 6 others RecruitingA Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)Researchers are looking for new ways to treat ovarian cancer (OC). Current treatment for OC may start with surgery to remove as much of the cancer as possible.NCT07776691·Washington D.C., District of Columbia and 12 others

Ovarian Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingStudy of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsThis is a multicenter Phase 1b, open-label study to assess safety, tolerability, preliminary efficacy, and pharmacokinetics (PK) of cabozantinib taken in combination with…NCT03170960·Gilbert, Arizona and 123 others

Active not recruitingA Trial of Vigil for Participants With Ovarian CancerThe goal of this clinical trial is to compare participants with ovarian, fallopian tube or primary peritoneal cancer when treated with investigational product (Vigil) compared to…NCT02346747·Mobile, Alabama and 25 others

TerminatedPaclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00023907·Phoenix, Arizona and 43 others

CompletedPhase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or LymphomaThe primary objectives of this Phase 1b/2 study were as follows: * Phase 1b (Bolus and Infusion): To evaluate the safety and tolerability of carfilzomib in patients with relapsed…NCT00531284·Scottsdale, Arizona and 6 others

TerminatedHKT288 in Solid Tumors, Including Epithelial Ovarian Cancer and Renal Cell CarcinomaA first-in-human study using HKT288 in solid tumors, including epithelial ovarian cancer and renal cell carcinomaNCT02947152·Houston, Texas and 5 others

RecruitingA Study of MT-4561 in Patients With Various Advanced Solid TumorsThis is a First In Human (FIH), multicenter, open-label, Phase I/II study to evaluate safety, tolerability, Pharmacokinetics (PK), pharmacodynamics, and efficacy of MT-4561 in…NCT06943521·Los Angeles, California and 5 others

CompletedTopotecan Liposomes Injection for Small Cell Lung Cancer (SCLC), Ovarian Cancer and Other Advanced Solid TumorsA multi-center, open-label, two-arm, dose-escalation study to establish the safety, tolerability, MTD, and schedule of TLI administered intravenously as a 30 minute infusion in…NCT00765973·Detroit, Michigan and 1 other

CompletedA Study of ZYC300 Administered With Cyclophosphamide Pre-DosingThe purpose of this study is to evaluate the feasibility, safety, and tolerability of administering ZYC300 with Cyclophosphamide (Cytoxan).NCT00381173·Boston, Massachusetts and 1 other

RecruitingACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid TumorsThe study's purpose is to establish the safety and tolerability of IMA203/IMA203CD8 products with or without combination with nivolumab in patients with solid tumors that express…NCT03686124·Stanford, California and 20 others

CompletedLong-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRsLong-Term Follow-Up Study for Subjects Enrolled in the Phase I/II Study of Autologous T Cells Engineered using the Sleeping Beauty System to Express T cell Receptors (TCRs)…NCT05292859·Houston, Texas

CompletedStudy to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and AnorexiaStudy to compare the effects of the investigational new drug (PF-06946860) and a placebo on appetite and to find out how participants with advanced cancer and anorexia feel after…NCT04803305·Little Rock, Arkansas and 32 others

CompletedDurvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube CancerThis phase II trial studies how well durvalumab and tremelimumab work in treating participants with ovarian, primary peritoneal, or fallopian tube cancer that has come back or…NCT03026062·Houston, Texas

RecruitingStudy of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid TumorsThis Phase 1, multi-center, open-label, dose escalation and dose optimization study is designed to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PDx)…NCT06545942·Goodyear, Arizona and 17 others

TerminatedA Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC)Part 1: Dose Escalation.NCT04718675·Birmingham, Alabama and 23 others

RecruitingTargeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialThis ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing.NCT05564377·Birmingham, Alabama and 483 others

RecruitingAZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian CancerThe intention of the study is to demonstrate superiority of AZD5335 versus standard of care by assessment of progression-free survival (PFS) in women with high-grade…NCT07218809·Birmingham, Alabama and 298 others

RecruitingSynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or MesotheliomaThis first-in-human (FIH) trial is designed to assess the safety, feasibility, and potential activity of a single intravenous (IV) dose of SynKIR-110 administered to subjects with…NCT05568680·Tampa, Florida and 4 others

PreviousPage 34 of 38Next

Other Conditions in Texas

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia